Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score ANgiogenic Function at NOrmal TErm on Placenta 06/11/2019 OBSERVATIONAL unchanged 2,633.85 0 A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer 06/11/2019 INTERVENTIONAL unchanged 2,633.85 0 Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer 06/11/2019 INTERVENTIONAL unchanged 2,633.85 0 Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) 06/12/2019 INTERVENTIONAL unchanged 2,632.85 0 A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients 06/12/2019 OBSERVATIONAL unchanged 2,632.85 0 Sexual Health Empowerment for Women's Health 06/13/2019 INTERVENTIONAL unchanged 2,631.85 0 Reproductive Axis Maturation in the Early Post-Menarchal Years 06/14/2019 OBSERVATIONAL unchanged 2,630.85 0 Exercise Treatment With Standard Therapy for Metastatic Breast Cancer 06/17/2019 INTERVENTIONAL unchanged 2,627.85 0 Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation 06/18/2019 INTERVENTIONAL unchanged 2,626.85 0 Primary Ovarian Insufficient Patients 06/18/2019 OBSERVATIONAL unchanged 2,626.85 0 Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial 06/19/2019 INTERVENTIONAL unchanged 2,625.85 0 PCOS (Polycystic Ovarian Syndrome) Patients 06/19/2019 OBSERVATIONAL unchanged 2,625.85 0 Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab 06/20/2019 OBSERVATIONAL unchanged 2,624.85 0 Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey 06/21/2019 INTERVENTIONAL unchanged 2,623.85 0 Palliative Radiation for Advanced Cervical Cancer 06/25/2019 INTERVENTIONAL unchanged 2,619.85 0 Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) 06/26/2019 INTERVENTIONAL unchanged 2,618.85 0 Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer 06/28/2019 INTERVENTIONAL unchanged 2,616.85 0 Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery 07/01/2019 INTERVENTIONAL unchanged 2,613.85 0 Hepcidin and Glucose Metabolism 07/05/2019 INTERVENTIONAL unchanged 2,609.85 0 Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium 07/05/2019 INTERVENTIONAL unchanged 2,609.85 0 Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast 07/05/2019 INTERVENTIONAL unchanged 2,609.85 0 Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour 07/08/2019 INTERVENTIONAL unchanged 2,606.85 0 Vital Signs-Integrated Patient-Assisted Intravenous Opioid Analgesia for Post Surgical Pain 07/08/2019 INTERVENTIONAL unchanged 2,606.85 0 Arm and Finger Measurement for Blood Pressure Surveillance 07/09/2019 OBSERVATIONAL unchanged 2,605.85 0 Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women 07/10/2019 OBSERVATIONAL unchanged 2,604.85 0 Evaluation of Central Sensitization, Fear-Avoidance, and Pain-Pressure Threshold With Chronic Pain After Hysterectomy 07/10/2019 OBSERVATIONAL unchanged 2,604.85 0 FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery 07/11/2019 INTERVENTIONAL unchanged 2,603.85 0 Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes. 07/15/2019 INTERVENTIONAL unchanged 2,599.85 0 Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients 07/17/2019 OBSERVATIONAL unchanged 2,597.85 0 NeoVax With Nivolumab in Patients With Ovarian Cancer 07/18/2019 INTERVENTIONAL unchanged 2,596.85 0 Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery 07/18/2019 INTERVENTIONAL unchanged 2,596.85 0 Deceased Uterine Transplant in Absolute Uterine Infertility (AUIF) 07/19/2019 INTERVENTIONAL unchanged 2,595.85 0 Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients 07/24/2019 INTERVENTIONAL unchanged 2,590.85 0 Transcriptional and Epigenetic Program of PCOS Women 07/26/2019 OBSERVATIONAL unchanged 2,588.85 0 Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer 07/29/2019 INTERVENTIONAL unchanged 2,585.85 0 Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. 07/31/2019 INTERVENTIONAL unchanged 2,583.85 0 A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer 07/31/2019 INTERVENTIONAL unchanged 2,583.85 0 Laser Vaginal Treatment for GSM 08/02/2019 INTERVENTIONAL unchanged 2,581.85 0 Bioenergetic Effects of Aging and Menopause (BEAM) 08/02/2019 INTERVENTIONAL unchanged 2,581.85 0 LASER and Radiofrequency and Genitourinary Syndrome of Menopause 08/05/2019 INTERVENTIONAL unchanged 2,578.85 0 Vaginal Microbiota Transplant 08/06/2019 INTERVENTIONAL unchanged 2,577.85 0 Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA 08/07/2019 INTERVENTIONAL unchanged 2,576.85 0 Perioperative Mindfulness Proposal 08/08/2019 INTERVENTIONAL unchanged 2,575.85 0 IDENTIFY Study: Natural History of Maternal Neoplasia 08/08/2019 INTERVENTIONAL unchanged 2,575.85 0 Improving Cognition After Cancer 08/08/2019 INTERVENTIONAL unchanged 2,575.85 0 Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer 08/08/2019 INTERVENTIONAL unchanged 2,575.85 0 Autonomic Determinants of POTS - Pilot1 08/08/2019 INTERVENTIONAL unchanged 2,575.85 0 DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast 08/12/2019 INTERVENTIONAL unchanged 2,571.85 0 Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study 08/12/2019 INTERVENTIONAL unchanged 2,571.85 0 Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC 08/13/2019 INTERVENTIONAL unchanged 2,570.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology